Patents by Inventor Russell Gettig

Russell Gettig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Poxvirus-rabies recombinants and compositions and methods employing the recombinants
    Patent number: 7144578
    Abstract: Recombinant viruses containing DNA coding for a rabies virus antigen, such as rabies virus G are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom are useful for eliciting an immunological against rabies virus, and, the gene products and antibodies elicited thereby are useful in assays.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: December 5, 2006
    Assignee: Connaught Technology Corporation
    Inventors: Enzo Paoletti, James Tartaglia, Jill Taylor, Russell Gettig
  • Poxvirus-canine destemper virus (CDV) recombinants and compositions and methods employing the recombinant
    Publication number: 20030082204
    Abstract: Attenuated recombinant viruses containing DNA coding for a canine distemper virus antigen or measles M or N antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: canine distemper virus fusion protein, canine distemper virus hemagglutinin glycoprotein, canine distemper nucleocaspid portein, canine distemper matrix protein, measles virus nucleocaspid protein, and measles virus matrix protein. The recombinant viruses and gene products therefrom are useful for eliciting protection against canine distemper virus and/or measles virus, and, the gene products and antibodies elicited thereby are useful in assays. Additionally, DNA from the recombinants is used for probes or for generating PCR primers.
    Type: Application
    Filed: September 13, 2001
    Publication date: May 1, 2003
    Applicant: Aventis Pasteur.
    Inventors: Enzo Paoletti, James Tartaglia, Jill Taylor, Russell Gettig
  • Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
    Patent number: 6309647
    Abstract: Attenuated recombinant viruses containing DNA coding for a canine distemper virus antigen or measles M or N antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: canine distemper virus fusion protein, canine distemper virus hemagglutinin glycoprotein, canine distemper nucleocaspid protein, canine distemper matrix protein, measles virus nucleocaspid protein, and measles virus matrix protein. The recombinant viruses and gene products therefrom are useful for eliciting protection against canine distemper virus and/or measles virus, and, the gene products and antibodies elicited thereby are useful in assays. Additionally, DNA from the recombinants is used for probes or for generating PCR primers.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: October 30, 2001
    Assignee: Aventis Pasteur
    Inventors: Enzo Paoletti, James Tartaglia, Jill Taylor, Russell Gettig
  • Infectious bursal disease virus recombination poxvirus vaccine
    Patent number: 5891442
    Abstract: What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from infectious bursal disease virus. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 6, 1999
    Assignee: Virogenetics Corporation
    Inventors: Enzo Paoletti, Jill Taylor, Russell Gettig
  • Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
    Patent number: 5858373
    Abstract: Attenuated recombinant viruses containing DNA encoding FIPV antigen(s) compositions thereof, as well as methods for making and using the compositions, expression products therefrom, and antibodies generated, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The compositions and products therefrom and antibodies generated have several preventive, therapeutic and diagnostic uses.
    Type: Grant
    Filed: December 1, 1995
    Date of Patent: January 12, 1999
    Assignee: Virogenetics Corporation
    Inventors: Enzo Paoletti, Russell Gettig
  • Infectious bursal disease virus recombinant poxvirus vaccine
    Patent number: 5641490
    Abstract: What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from infectious bursal disease virus. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: June 24, 1997
    Assignee: Virogenetics Corporation
    Inventors: Enzo Paoletti, Jill Taylor, Russell Gettig